Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

Share Price is delayed by 15 minutes
Get Live Data
157.50    3.50 (2.27%)
Bid:
155.00
Ask:
160.00
Spread: 5.00 (3.226%)
Market Cap: £184.78m
SUP Live PriceLast checked at - London Stock Exchange

Intraday Supreme Plc Share Chart

Trading Update

4 May 2021 07:00

RNS Number : 2996X
Supreme PLC
04 May 2021
 

4 May 2021

 

Supreme plc

("Supreme," the "Company" or the "Group")

 

Trading Update 

 

- Strong performance across key growth categories

- Adjusted EBITDA ahead of expectations

 

Supreme (AIM:SUP), a leading manufacturer, supplier and brand owner of fast-moving consumer products, provides a trading update for the year ended 31 March 2021.

 

The Company performed strongly throughout the period, generating high levels of demand across all its core categories, which include batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. This excellent performance, delivered against the backdrop of the Covid-19 pandemic and the associated restrictions, reinforces the Company's resilience, the strength of its brands and the importance of its diverse routes to market and extensive retail network including 3,300 active accounts across wholesale, discount, supermarket, high street, international and public sector customers, in addition to 70,000 active online accounts.

 

For the year ended 31 March 2021, Supreme expects to report a c. 30% increase in revenues to at least £121 million (2020: £92.3 million), in-line with management's expectations, and anticipates delivering Adjusted EBITDA1 slightly ahead of expectations of at least £19 million (2020: £16.2 million), an increase of c. 20%. Movements in Group margin reflect the changes in revenue mix following the acquisition of Provider Distribution in February 2020 which are partially offset by stronger growth in higher margin products in Vaping and Sports Nutrition & Wellness.

 

The Group remains highly cash generative, with net debt at 31 March 2021 of approximately £5.1 million (31 March 2020: £18.7 million).

 

The Group also maintained high levels of business continuity throughout the year, both at its manufacturing site and across its distribution network, whilst adhering to government guidelines and prioritising the health and safety of its employees.

 

Specifically, the Group benefitted from significant demand across Vaping and Sports Nutrition & Wellness during the year, delivering a 35% increase in revenues in its Vaping division with its 88Vape brand continuing to achieve strong customer traction, as demonstrated by the recent announcement regarding its roll-out across McColl's entire store estate. Furthermore, the Group's Sports Nutrition & Wellness category delivered 38% growth underpinned by the success of the acquisition of Battle Bites protein snack bars in October 2020, the expansion of the powdered protein range into meal replacements under the Solo brand and the early success of private label vitamins, which will be further complemented by additional product launches later this year.

 

The board and management of Supreme continue to monitor the Covid-19 situation very closely and remain confident in the outlook for the business this financial year and beyond. 

 

Sandy Chadha, Chief Executive Officer of Supreme, commented:

 

"I am delighted to provide our first trading update since our AIM admission in February 2021. We continue to build on our strong track record of growth, with our strategy to focus on high growth categories such as vaping and sports nutrition really coming to fruition.

 

"Innovation and entrepreneurship continue to be at the heart of what we do and our exciting pipeline of new products, coupled with the potential to increase the penetration of our existing categories, continues to be underpinned by our market leading distribution network.

 

"The new financial year has started well and we are looking ahead with confidence on delivering on our expectations."

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Communications

 

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett / Samantha Harrison / Harrison Clarke

 

+44 (0)20 7383 5100

Berenberg (Broker)

Chris Bowman / Mark Whitmore / Jen Clarke

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Antonia Pollock

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

About Supreme

 

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, The Range, Sports Direct, Londis, SPAR, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness.

 

www.investors.supreme.co.uk

 

1 Adjusted EBITDA means operating profit before depreciation, amortisation, share-based payments charge, fair value movements on non-hedge accounted derivatives and exceptional items (including all IPO-related costs)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQBLFXFZLBBBB
Date   Source Headline
12th Jul 20229:30 amRNSHolding(s) in Company
12th Jul 20229:19 amRNSDirector Share Purchase
8th Jul 20225:14 pmRNSHolding(s) in Company
6th Jul 202212:34 pmRNSHolding(s) in Company
5th Jul 202211:05 amRNSSecond Price Monitoring Extn
5th Jul 202211:00 amRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSFinal Results
21st Jun 20227:00 amRNSNotice of Results & Investor Presentation
13th Jun 20227:00 amRNSAcquisition of Liberty Flights Holdings Limited
10th May 20227:00 amRNSSale of McColl's Retail Group
28th Apr 202212:35 pmRNSHolding(s) in Company
14th Apr 202212:00 pmRNSInvestor Presentation
12th Apr 20229:05 amRNSSecond Price Monitoring Extn
12th Apr 20229:00 amRNSPrice Monitoring Extension
12th Apr 20227:00 amRNSYear End Trading Update
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:01 pmRNSPrice Monitoring Extension
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:00 amRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSHalf-year Results
30th Nov 202111:30 amRNSInvestor Presentation
18th Oct 20217:07 amRNSTrading Update & Notice of Results
30th Sep 20213:05 pmRNSResults of AGM
31st Aug 20217:00 amRNSAvailability of Annual Report & Notice of AGM
20th Jul 20217:00 amRNSUnaudited Preliminary Results
19th Jul 20217:00 amRNSLaunch of Sealions Vitamin brand
8th Jul 20217:00 amRNSNotice of Results & Investor Presentation
1st Jul 20217:00 amRNSAcquisition of brands of SCI-MX Limited
11th Jun 20217:00 amRNSAcquisition of Vendek Limited
9th Jun 20217:00 amRNSExercise of options and total voting rights
4th May 20217:00 amRNSTrading Update
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
19th Mar 20211:13 pmRNSGrant of Options under 2021 SAYE Scheme
15th Mar 20217:00 amRNSCompletion of McColl’s roll-out
10th Mar 20217:00 amRNSDirector/PDMR Shareholding
1st Mar 20219:00 amRNSPrice Monitoring Extension
2nd Feb 20214:37 pmRNSHolding(s) in Company
1st Feb 20217:00 amRNSAIM Admission & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.